Medrx Co (4586.T) Stock Price

Medrx Co Price

CLOSED
38.00
​
Market closed

Revenue at Medrx Co has contracted by 4.2% per year over the past 18 years to 128.08 M JPY. For Medrx Co, the net margin of -731.8% is up versus -12,692.6% a few years ago.

Medrx Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medrx Co business model & stock analysis

Medrx Co. Ltd. develops pharmaceutical drugs using transdermal absorption technology, focusing on percutaneous absorption through ionic liquid transdermal system (ILTS) and nano-sized colloid transdermal system (NCTS). The company aims to maximize drug efficacy, reduce side effects, and provide alternatives for patients who cannot take oral medications. Its products target new markets by offering medicines with enhanced delivery systems and added value. The firm's technology includes ionic liquid transdermal system (ILTS) leveraging ionic liquid characteristics and nano-sized colloid transdermal system (NCTS) utilizing nano colloidization technology. These systems enable precise drug delivery, addressing challenges in oral administration and improving patient compliance. The company's products are designed to serve patients requiring non-oral medication options. Medrx Co. Ltd. produces medicines based on percutaneous absorption formulation technology, targeting healthcare providers and patients who need alternative drug administration methods. The company's focus on transdermal systems allows it to address specific medical needs, such as preventing forgotten doses and reducing side effects associated with traditional oral drugs.

Frequently asked questions about Medrx Co

Converted at the current exchange rate, the Medrx Co share trades at 0.22 EUR (38.00 JPY).

The revenue cannot currently be calculated for Medrx Co.

The profit cannot currently be calculated for Medrx Co.

The P/E ratio cannot be calculated for Medrx Co at the moment.

The P/S cannot be calculated for Medrx Co currently.

The Eulerpool Quality Score for Medrx Co is 5/10.

The ISIN of Medrx Co is JP3921220004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Medrx Co is 4586.T. The ticker symbol is used to trade Medrx Co shares on the stock exchange.

Fair ValueTerminal
36.86 JPY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
5.82 M JPY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website medrx.co.jp
Country
Currency
JPY
Initial public offering
Feb 13, 2013
ISIN
JP3921220004
Cusip
J41574104
Market capitalization
2.26 B JPYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
—
P/Se
—
EV/EBIT
—
P/B Ratio
1.10
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-45.75 %
Last updated Nov 19, 2026, 3:48 AM

Medrx Co Peer Group

Medrx Co FIGI

4586:JP · BBG003S4JL614586:JT · BBG003T0NXY64586:JJ · BBG003T0NY744586:JE · BBG003T0NYB94586:JI · BBG003T0NYC84586:JU · BBG003T0NYD74586:JW · BBG00875LDH34586:JV · BBG0193RCVW9

All fundamentals and in-depth analysis of Medrx Co

Our stock analysis for Medrx Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medrx Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.